Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of NewAmsterdam Pharma Company NV (NASDAQ: NAMS) closed at $19.22 in the last session, up 4.63% from day before closing price of $18.37. In other words, the price has increased by $4.63 from its previous closing price. On the day, 0.62 million shares were traded.
Ratios:
We take a closer look at NAMS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 19.98 and its Current Ratio is at 19.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.Scotiabank initiated its Sector Outperform rating on March 14, 2024, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 11 ’25 when NAP PoolCo B.V. bought 1,433,193 shares for $15.12 per share.
Topper James N bought 1,135 shares of NAMS for $25,521 on Mar 26 ’25. The Director now owns 3,013,569 shares after completing the transaction at $22.49 per share. On Mar 26 ’25, another insider, Michael H. Davidson, who serves as the Affiliate of the company, bought 12,258 shares for $23.41 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 45.73 while its Price-to-Book (P/B) ratio in mrq is 2.77.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $27.29, while it has fallen to a 52-week low of $14.06. The 50-Day Moving Average of the stock is -2.92%, while the 200-Day Moving Average is calculated to be -3.26%.
Shares Statistics:
A total of 112.17M shares are outstanding, with a floating share count of 62.41M. Insiders hold about 44.41% of the company’s shares, while institutions hold 47.11% stake in the company.
